Literature DB >> 26803329

Nevirapine Plasma Concentrations in Human Immunodeficiency Virus-Exposed Neonates Receiving High-Dose Nevirapine Prophylaxis as Part of 3-Drug Regimen.

Michael A Bolaris1, Margaret A Keller1, Brian L Robbins2, Anthony T Podany2, Courtney V Fletcher2.   

Abstract

Entities:  

Keywords:  3-drug regimen; HIV-exposed; neonates; nevirapine

Mesh：

Substances：

Year:  2017        PMID： 26803329     DOI： 10.1093/jpids/piv084

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


× No keyword cloud information.
  2 in total

1.  Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.

Authors:  Tim R Cressey; Baralee Punyawudho; Sophie Le Coeur; Gonzague Jourdain; Chalermpong Saenjum; Edmund V Capparelli; Kanokwan Jittayanun; Siriluk Phanomcheong; Anita Luvira; Thitiporn Borkird; Achara Puangsombat; Leon Aarons; Pra-Ornsuda Sukrakanchana; Saik Urien; Marc Lallemant
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-15       Impact factor: 3.731

2.  Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study.

Authors:  Theodore D Ruel; Edmund V Capparelli; Camlin Tierney; Bryan S Nelson; Anne Coletti; Yvonne Bryson; Mark F Cotton; Stephen A Spector; Mark Mirochnick; Rebecca LeBlanc; Christina Reding; Bonnie Zimmer; Deborah Persaud; Mutsa Bwakura-Dangarembizi; Kimesh L Naidoo; Rohan Hazra; Patrick Jean-Philippe; Ellen G Chadwick
Journal:  Lancet HIV       Date:  2020-11-23       Impact factor: 12.767
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.